Caliper Life Sciences, IntegenX enter license agreement for microfluidics patent portfolio


i-Micro News
IntegenX will leverage its proprietary MOVe™ microvalve technology and Caliper’s microfluidic intellectual patent estate to accelerate commercialization of its Apollo 200 RapidHIT™ DNA Profiling System for human identification.